{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:39:29Z","timestamp":1787506769937,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was partly supported by a research grant from SEKISUI MEDICAL."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12185-024-03883-0","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T20:57:27Z","timestamp":1733345847000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples"],"prefix":"10.1007","volume":"121","author":[{"given":"Naruto","family":"Shimonishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3046-6915","authenticated-orcid":false,"given":"Kenichi","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"6","key":"3883_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/ijlh.12109","volume":"35","author":"AS Lawrie","year":"2013","unstructured":"Lawrie AS, Kitchen S, Efthymiou M, Mackie IJ, Machin SJ. Determination of APTT factor sensitivity\u2014the misguiding guideline. Int J Lab Hematol. 2013;35(6):652\u20137.","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"3883_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0038-1677018","volume":"45","author":"EJ Favaloro","year":"2019","unstructured":"Favaloro EJ, Kershaw G, Mohammed S, Lippi G. How to optimize activated partial thromboplastin time (APTT) testing: solutions to establishing and verifying normal reference intervals and assessing APTT reagents for sensitivity to heparin, lupus anticoagulant, and clotting factors. Semin Thromb Hemost. 2019;45(1):22\u201335.","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"3883_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/PAT.0b013e328353254d","volume":"44","author":"G Kershaw","year":"2012","unstructured":"Kershaw G, Favaloro EJ. Laboratory identification of factor inhibitors: an update. Pathology. 2012;44(4):293\u2013302.","journal-title":"Pathology"},{"issue":"1","key":"3883_CR4","first-page":"73","volume":"96","author":"EJ Favaloro","year":"2006","unstructured":"Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, et al. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation. Thromb Haemost. 2006;96(1):73\u20138.","journal-title":"Thromb Haemost"},{"key":"3883_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-1-4939-7196-1_23","volume":"1646","author":"G Kershaw","year":"2017","unstructured":"Kershaw G. Detection and measurement of factor inhibitors. Methods Mol Biol. 2017;1646:295\u2013304.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"3883_CR6","first-page":"19","volume":"10","author":"DW Sborov","year":"2012","unstructured":"Sborov DW, Rodgers GM. Acquired hemophilia a: a current review of autoantibody disease. Clin Adv Hematol Oncol. 2012;10(1):19\u201327.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"5","key":"3883_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1182\/blood.V49.5.793.793","volume":"49","author":"TS Lossing","year":"1977","unstructured":"Lossing TS, Kasper CK, Feinstein DI. Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 1977;49(5):793\u20137.","journal-title":"Blood"},{"issue":"6","key":"3883_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2141.2006.06087.x","volume":"133","author":"CR Hay","year":"2006","unstructured":"Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol. 2006;133(6):591\u2013605.","journal-title":"Br J Haematol"},{"issue":"3","key":"3883_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/s-0033-1336832","volume":"39","author":"G Kershaw","year":"2013","unstructured":"Kershaw G, Orellana D. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thromb Hemost. 2013;39(3):283\u201390.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"3883_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1309\/RREK-8L6M-D2KC-HWLH","volume":"117","author":"SH Chang","year":"2002","unstructured":"Chang SH, Tillema V, Scherr D. A \u201cpercent correction\u201d formula for evaluation of mixing studies. Am J Clin Pathol. 2002;117(1):62\u201373.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"3883_CR11","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1515\/cclm-2018-0794","volume":"57","author":"N Tang","year":"2019","unstructured":"Tang N, Chen Y, Li D, Yin S. Determining the cutoff value of the APTT mixing test for factor VIII inhibitor. Clin Chem Lab Med. 2019;57(5):e88\u201390.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"3883_CR12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1055\/s-0038-1657690","volume":"78","author":"PJ Braun","year":"1997","unstructured":"Braun PJ, Givens TB, Stead AG, Beck LR, Gooch SA, Swan RJ, Fischer TJ. Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb Haemost. 1997;78(3):1079\u201387.","journal-title":"Thromb Haemost"},{"issue":"7","key":"3883_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/jth.12287","volume":"11","author":"M Shima","year":"2013","unstructured":"Shima M, Thachil J, Nair SC, Srivastava A, Scientific, Standardization C. Towards standardization of clot waveform analysis and recommendations for its clinical applications. J Thromb Haemost. 2013;11(7):1417\u201320.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"3883_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1055\/s-0037-1613023","volume":"87","author":"M Shima","year":"2002","unstructured":"Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, et al. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb Haemost. 2002;87(3):436\u201341.","journal-title":"Thromb Haemost"},{"issue":"5","key":"3883_CR15","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1111\/hae.13266","volume":"23","author":"T Matsumoto","year":"2017","unstructured":"Matsumoto T, Nogami K, Tabuchi Y, Yada K, Ogiwara K, Kurono H, et al. Clot waveform analysis using CS-2000i\u2122 distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A. Haemophilia. 2017;23(5):e427\u201335.","journal-title":"Haemophilia"},{"issue":"3","key":"3883_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/jth.12488","volume":"12","author":"J Haku","year":"2014","unstructured":"Haku J, Nogami K, Matsumoto T, Ogiwara K, Shima M. Optimal monitoring of bypass therapy in hemophilia A patients with inhibitors by the use of clot waveform analysis. J Thromb Haemost. 2014;12(3):355\u201362.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"3883_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s12185-020-02837-6","volume":"111","author":"S Ochi","year":"2020","unstructured":"Ochi S, Takeyama M, Shima M, Nogami K. Plasma-derived factors VIIa and X mixtures (Byclot \u00ae) significantly improve impairment of coagulant potential ex vivo in plasmas from acquired hemophilia A patients. Int J Hematol. 2020;111(6):779\u201385.","journal-title":"Int J Hematol"},{"key":"3883_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12185-016-2108-x","volume":"105","author":"T Matsumoto","year":"2017","unstructured":"Matsumoto T, Nogami K, Shima M. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity. Int J Hematol. 2017;105:174\u201383.","journal-title":"Int J Hematol"},{"issue":"6","key":"3883_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1055\/s-0040-1721776","volume":"121","author":"N Shimonishi","year":"2021","unstructured":"Shimonishi N, Ogiwara K, Oda Y, Kawabe T, Emmi M, Shima M, Nogami K. Inhibitor index in the clot waveform analysis-based mixing test differentiates among hemophilia A without and with inhibitors, and lupus anticoagulant. Thromb Haemost. 2021;121(6):792\u20139.","journal-title":"Thromb Haemost"},{"issue":"2","key":"3883_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1055\/s-0040-1715838","volume":"121","author":"N Shimonishi","year":"2021","unstructured":"Shimonishi N, Ogiwara K, Oda Y, Kawabe T, Okazaki S, Shima M, Nogami K. A novel assessment of factor VIII activity by template matching utilizing weighted average parameters from comprehensive clot waveform analysis. Thromb Haemost. 2021;121(2):164\u201373.","journal-title":"Thromb Haemost"},{"issue":"2","key":"3883_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1055\/s-0038-1651083","volume":"57","author":"E Rosner","year":"1987","unstructured":"Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost. 1987;57(2):144\u20137.","journal-title":"Thromb Haemost"},{"key":"3883_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.thromres.2016.01.019","volume":"139","author":"GW Moore","year":"2016","unstructured":"Moore GW, Culhane AP, Daw CR, Noronha CP, Kumano O. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant. Thromb Res. 2016;139:98\u2013101.","journal-title":"Thromb Res"},{"issue":"4","key":"3883_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/rth2.12245","volume":"3","author":"O Kumano","year":"2019","unstructured":"Kumano O, Moore GW. Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant. Res Pract Thromb Haemost. 2019;3(4):695\u2013703.","journal-title":"Res Pract Thromb Haemost"},{"issue":"11","key":"3883_CR24","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.5858\/arpa.2021-0123-OA","volume":"146","author":"C Liu","year":"2022","unstructured":"Liu C, Ling L, Huang X, Mi J, Liao J, Jia J, et al. Evaluation of activated partial thromboplastin time mixing studies using several methods. Arch Pathol Lab Med. 2022;146(11):1387\u201394.","journal-title":"Arch Pathol Lab Med"},{"key":"3883_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.thromres.2016.05.004","volume":"143","author":"O Kumano","year":"2016","unstructured":"Kumano O, Ieko M, Naito S, Yoshida M, Takahashi N, Suzuki T, Komiyama Y. New formulas for mixing test to discriminate between lupus anticoagulant and acquired hemophilia A. Thromb Res. 2016;143:53\u20137.","journal-title":"Thromb Res"},{"issue":"10","key":"3883_CR26","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009;7(10):1737\u201340.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"3883_CR27","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1111\/j.1538-7836.2012.04906.x","volume":"10","author":"O Kumano","year":"2012","unstructured":"Kumano O, Ieko M, Naito S, Yoshida M, Takahashi N. APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent. J Thromb Haemost. 2012;10(11):2338\u201343.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3883_CR28","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1515\/cclm-2015-0670","volume":"54","author":"EN Dumoulin","year":"2016","unstructured":"Dumoulin EN, Fiers L, Devreese KM. Investigation of sensitivity for coagulation factor deficiency in APTT and PT: how to perform it? Clin Chem Lab Med. 2016;54(5):e169\u201372.","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"3883_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/ijlh.12424","volume":"37","author":"M Martinuzzo","year":"2015","unstructured":"Martinuzzo M, Barrera L, Rodriguez M, D\u2019Adamo MA, Lopez MS, Otaso JC. Do PT and APTT sensitivities to factors\u2019 deficiencies calculated by the H47\u2013A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients? Int J Lab Hematol. 2015;37(6):853\u201360.","journal-title":"Int J Lab Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03883-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03883-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03883-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T11:35:30Z","timestamp":1738236930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03883-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3883"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03883-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NS, KO, and KN received research support from SEKISUI MEDICAL CO., LTD. KN received honoraria from this company. KO, TK, TN are employees of SEKISUI MEDICAL CO., LTD. NS, KO, KN. and TK have patents to these methods relating to CWA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}